Health xChange: Giving patients end of life choice through less tech.—defibrillators vs pacemakers скачать в хорошем качестве

Health xChange: Giving patients end of life choice through less tech.—defibrillators vs pacemakers

Giving patients end of life choice through less technology: Defibrillators vs pacemakers On Vancouver Island we serve ~1,500 patients with ICDs (implantable cardioverter defibrillators), which function as pacemaker and deliver a high energy, potentially painful shock as needed. Such shocks are lifesaving but as patients age, they may no longer wish to have painful shocks to prevent sudden death. However, there is currently no safe way to downgrade a defibrillator to a simple, painless pacemaker. Our work is designing and deploying an inexpensive new device that allows patients previously treated with an ICD to be transitioned to a pacemaker that will prevent inappropriate treatments in frail patients and render savings to healthcare systems worldwide. Dr. Josh Giles is the director of the Orthopaedic Technologies and Biomechanics Lab at the University of Victoria and is a Michael Smith Health Research BC Scholar award. His lab primarily focuses on developing technologies to improve care of musculoskeletal and orthopaedic conditions while also pursuing medical device development projects in other fields through collaborations with clinician scientists. The technologies the lab focuses on are: improving patient diagnosis and assessment, aiding surgeons while planning surgical interventions, and increasing the efficacy of implantable devices to improve patient outcomes and quality of life. Dr. Markus Sikkel is a cardiac electrophysiologist in Victoria. His clinical practice focuses on treatment of cardiac arrhythmias through implantation of cardiac devices and ablation techniques. His PhD was in spontaneous sarcoplasmic reticulum calcium release and how this can lead to cardiac arrhythmias. His current research interests include gaining a deeper understanding of the biology and physiology of acquired cardiac disease, using this understanding to design novel therapeutic methods to treat acquired cardiac disease more effectively than the standard current of care, and in understanding when expensive and invasive therapies are likely to be futile in cardiology. --- To grow research capacity on Vancouver Island, Health Research BC partnered with Island Healthand the Victoria Hospitals Foundationfor the first Health xChange in Victoria, BC. This free public knowledge exchange and networking event was the first to showcase the innovative solutions transforming health care on Vancouver Island. Members of the public learned more about local health research. Researchers, clinicians and health care professionals discovered opportunities for collaboration and knowledge sharing. Network with the scientists, clinicians, researchers, patients, partners, and others at the cutting edge of BC health research. Using a Pecha Kuchaformat of 20 slides presented for only 20 seconds, each 6 minute and 40 second presentation was delivered in a highly accessible and engaging fashion, including opportunity for questions. During this hybrid event, health research leaders presented a broad spectrum of cutting-edge research projects that are enhancing patient care and health outcomes.